EM2205G "Understanding and Addressing Health Disparities in Liver Disease and Liver Cancer" (IM GR-052022)
Purpose and Overview
Chronic liver disease is the fourth leading cause of death among U.S. adults aged 45-64, accounting for >44,000 deaths annually. Further, chronic liver disease results in a significant burden of disability, hospitalizations and health care resource utilization, with inpatient costs alone exceeding $18.8 billion in 2016. The burden of chronic liver disease and hepatocellular carcinoma (HCC), the most common type of primary liver cancer, is unequally distributed in the U.S. with men, racial and ethnic minorities, and socioeconomically disadvantaged persons being disproportionately affected. Although this disparity in liver disease incidence and mortality has been consistently observed, data are limited on the specific determinants driving inequitable outcomes. Underlying causes are complex and related to a combination of patient-level, provider-level, system-level and societal factors. Understanding the current landscape of racial, ethnic, gender, and socioeconomic disparities in chronic liver disease and HCC is the necessary first step to identify intervention targets to promote health equity for all patients with liver disease.
UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.
At the conclusion of this activity, the participant should be able to:
- Describe demographic trends in the burden of liver disease and liver cancer in the U.S.
- Understand how social and structural issues can cause health disparities and adversely affect liver disease outcomes
- Identify specific patient-level, provider-level, system-level and societal determinants of health disparities in liver disease and liver cancer
- 1.00 AMA